The prevailing view treats senescent cells as either helpful (temporary) or harmful (accumulated), with approaches like intermittent fasting or senolytics aiming to shrink their numbers. But this either/or framework overlooks something interesting: the same senescent cell might actually shift its SASP depending on metabolic conditions. If that's true, senolytics could be wiping out useful cellular mediators too early.

Here's the mechanism I'm proposing: β-hydroxybutyrate (BHB), which rises during fasting, might act as a metabolic switch that reprograms senescent cell SASP from pro-inflammatory (IL-6, IL-8, MMPs) toward pro-reparative signals (CCN1, PDGF-AA, VEGF) without killing the cells. This would work through BHB's histone deacetylase inhibition, changing which SASP genes get transcribed, plus signaling through GPR109A to dampen NF-κB while activating Nrf2 antioxidant responses. The testable outcome: treating senescent fibroblasts with BHB should cut IL-6 secretion by at least half while keeping CCN1 and PDGF-AA steady or boosting them compared to untreated controls.

Why this matters: if we can metabolically reprogram senescent cells rather than eliminate them, intermittent fasting becomes less about clearance and more about restoring proper cellular communication. This challenges the senolytic approach—maybe we don't need fewer senescent cells, just better metabolic conditions for them.

A few specific predictions to test this:

1. BHB treatment (3mM, 48 hours) of IR-induced senescent dermal fibroblasts will decrease IL-6/IL-8 levels while increasing CCN1/Wnt5a on Western blot, compared to vehicle controls.

2. In aged mice, four weeks of intermittent fasting will lower circulating IL-6 but preserve tissue CCN1 relative to ad libitum-fed controls, while leaving p16INK4a+ cell numbers unchanged—different from what you'd see with senolytic treatment.

3. RNA-seq of BHB-treated senescent cells will show histone acetylation changes at SASP gene promoters and suppressed NF-κB pathway activity.

This is falsifiable—if BHB doesn't actually shift SASP composition, or if intermittent fasting reduces senescent cell burden without any SASP changes, the whole idea falls apart. But if it holds up, we'd have a framework linking ketone metabolism, epigenetic regulation, and cellular communication in a way that changes how we think about aging interventions.